Revanesse Versa
Revanesse Versa, or Versa as it is known as, is a cross-linked hyaluronic acid filler that is similar to Juvederm or Restylane products. The product was approved for use in the U.S. by the Food and Drug Administration in 2017 for the cosmetic treatment of facial wrinkles and creases and released to the U.S. market in 2019.
What makes this filler different than others on the market is the way it is manufactured. The gel substance is processed via an advanced wet milling technology and propriety formula which results in a uniformed size shape and smoothness of the end product. This newer technology has been proven in clinical studies to result in 24% less swelling after injection as compared to other dermal fillers. The spherical particle shape is more likely to be accepted by your body and therefore undergoes a slower Prollenium, the company who manufactures Versa, takes pride in producing smaller batches and a high standard of quality control by inspecting each syringe before leaving their North American manufacturing facility.
Call to schedule a consultation to learn more about Reveanesse Versa and if this filler will to address your aesthetic needs.